For a 17‑year‑old female with ADHD who had the best response to amphetamine/dextroamphetamine but experienced appetite suppression, is switching to immediate‑release Adderall (amphetamine/dextroamphetamine) an option, and could lisdexamfetamine (Vyvanse) be considered as an alternative?

Switching to Immediate-Release Adderall or Vyvanse for ADHD with Appetite Suppression

Yes, switching to immediate-release (IR) amphetamine/dextroamphetamine (Adderall) is a reasonable option, and lisdexamfetamine (Vyvanse) is also a viable alternative, though it may not substantially reduce appetite suppression since both are amphetamine-based medications.

Understanding the Clinical Context

Since this 17-year-old had the best response to amphetamine/dextroamphetamine but experienced problematic appetite suppression, you're dealing with a medication that works well for ADHD symptoms but has a dose-limiting side effect. The key question is whether changing the formulation or switching to a related amphetamine prodrug will maintain efficacy while reducing the appetite impact.

Immediate-Release Amphetamine/Dextroamphetamine Option

Switching to IR formulations can be strategically beneficial for managing appetite suppression 1. Here's why:

• Timing flexibility: IR formulations allow you to dose around meals. You can administer doses after breakfast and lunch rather than before, potentially preserving appetite during key eating times 1
• Shorter duration of action: The appetite-suppressing effects wear off more quickly with IR formulations (3-4 hours vs. extended-release 8-12 hours), creating windows where appetite returns 2
• Dose splitting: You can use smaller individual doses multiple times daily (typically 2-3 times), which may reduce peak appetite suppression while maintaining symptom control throughout the day 1

Critical caveat: IR formulations require multiple daily doses (typically 2-3 times), which can reduce medication adherence—a common problem in ADHD treatment 2. You'll need to weigh improved appetite management against potential adherence challenges.

Lisdexamfetamine (Vyvanse) as an Alternative

Lisdexamfetamine is a reasonable alternative but unlikely to substantially reduce appetite suppression 3. Here's the evidence:

Why It Might Help:

• Smoother pharmacokinetic profile: As a prodrug, lisdexamfetamine is converted to dextroamphetamine gradually through red blood cell metabolism, creating a more gradual rise and fall in drug levels 3
• Once-daily dosing: Improves adherence compared to IR formulations 4, 5
• Duration of 12 hours: Provides full-day coverage 4, 5
• Proven efficacy: Demonstrated superior efficacy to atomoxetine and comparable efficacy to osmotic-release methylphenidate in adolescents with ADHD 6

Why It May Not Solve the Appetite Problem:

• Same active metabolite: Lisdexamfetamine converts to dextroamphetamine—the same active compound causing appetite suppression in the current medication 3
• Appetite suppression remains common: Decreased appetite is one of the most common adverse effects (>10% incidence) with lisdexamfetamine 4, 5, 7
• All-day effect: The 12-hour duration means appetite suppression persists throughout the day, potentially affecting multiple meals 4

Practical Management Algorithm

Step 1: Optimize Current Medication First

Before switching, ensure you've tried:

• Dose timing: Administer after meals rather than before
• Nutritional strategies: High-calorie breakfast before medication, protein shakes, calorie-dense snacks when appetite returns
• Monitor growth: Track height and weight monthly; stimulants can reduce growth velocity by 1-2 cm from predicted adult height, particularly with higher, consistently administered doses 1

Step 2: If Optimization Fails, Choose Based on Priority

If maintaining efficacy is paramount and adherence is reliable:

• Switch to IR amphetamine/dextroamphetamine dosed 2-3 times daily after meals
• Start with equivalent total daily dose divided (e.g., if on 30mg extended-release, try 10mg IR three times daily)
• Dose after breakfast and lunch to preserve appetite during meals

If adherence is a concern or once-daily dosing is essential:

• Trial lisdexamfetamine at equivalent amphetamine dose
• Recognize that appetite suppression will likely persist but may be slightly smoother
• Implement aggressive nutritional strategies (high-calorie breakfast, evening meals when effect wanes)

Step 3: Monitor Closely

• Weight and height: Monthly measurements for first 3 months, then quarterly 1
• Cardiovascular parameters: Heart rate and blood pressure at each visit (stimulants increase HR by 1-2 bpm and BP by 1-4 mmHg on average, but 5-15% have more substantial increases) 1
• ADHD symptoms: Use standardized rating scales to ensure efficacy is maintained
• Appetite and nutrition: Daily food logs for first 2-4 weeks

Alternative Consideration: Non-Stimulants

If appetite suppression remains intolerable despite formulation changes, consider switching to atomoxetine, which shows "lower effects regarding decreased appetite and, consequently, fewer growth/height problems" compared to stimulants 2. However, this represents a second-line option with smaller effect sizes and 6-12 weeks until full therapeutic effect 2.

Key Pitfalls to Avoid

1. Don't assume lisdexamfetamine will eliminate appetite suppression—it's still an amphetamine with the same adverse effect profile 4, 5
2. Don't switch without first optimizing dose timing and nutritional strategies with the current medication
3. Don't neglect growth monitoring—stimulant-related growth suppression is real and requires systematic tracking 1
4. Don't overlook adherence challenges with IR formulations, especially in a 17-year-old who may resist multiple daily doses 2